13 results about "Peripheral thrombosis" patented technology

The invention relates to a collateral-dredging thrombus-removing traditional Chinese medicine composition for preventing and treating stroke, vascular thrombus, arteriosclerosis, coronary heart disease or waist and leg pain. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 12-65 parts of cooked rhubarb, 10-72 parts of salvia miltiorrhiza, 12-65 parts of cortex moutan, 6-57 parts of rhizoma zingiberis, 8-50 parts of pseudo-ginseng, 15-45 parts of obscured homalomena rhizome, 10-68 parts of leech, 7-76 parts of earthworm, 15-70 parts of ligusticum wallichii, 6-52 parts of Tibetan capillary artemisia, 7-49 parts of cape jasmine, 3-25 parts of borneol, 6-75 parts of angelica sinensis, 12-65 parts of ginseng, 7-53 parts of pogostemon cablin and 10-77 parts of radix curcumae. The medicine has the effects of promoting blood circulation, removing blood stasis, dredging collaterals and removing thrombus. The traditional Chinese medicine composition can be used for preparing medicines for treating cerebral apoplexy, coronary heart disease, arteriosclerosis and static artery thrombosis diseases, or medicines for soothing channels, activating collaterals and promoting blood circulation to remove blood stasis, which are related to waist and leg pain diseases. The invention provides a prevention and treatment effective solution for people with stroke, vascular thrombosis, arteriosclerosis, coronary heart disease or waist and leg pain.

The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for treating a tissue region (e.g., a tumor) through application of energy.

The invention discloses a 5 / 8 / 5 chitosan clostridium diterpenoid compound, a biosynthetic gene cluster and application of the biosynthetic gene cluster, and relates to the technical field of biological medicines. A 5 / 8 / 5 chitin type diterpenoid biosynthetic gene cluster Thm in trichoderma harzianum is identified through a genome mining system, chitin diterpenoid compounds with diversified structures are obtained by means of heterologous expression, the obtained compounds are subjected to anti-thrombotic activity comprehensive evaluation, and the result shows that the compounds 6 and 31 can obviously inhibit vascular thrombosis, the compound 6 has a remarkable inhibition effect on collagen-induced platelet aggregation, and the compound 31 has a better inhibition capability on thrombin-induced platelet activation. The compounds 6 and 31 show powerful antithrombotic effects in artery, vein and pulmonary artery thrombosis models, so that powerful technical support is provided for development of antithrombotic drugs.

The present invention relates to comprehensive systems, devices and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, systems, devices, and methods are provided for delivering energy to difficult to access tissue regions (e.g. peripheral lung tissues), and / or reducing the amount of undesired heat given off during energy delivery.

Provided herein are devices, systems, and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, devices, systems, and methods are provided for delivering energy to difficult to access tissue regions (e.g. central or peripheral lung tissues), and / or reducing the amount of undesired heat given off during energy delivery.

Provided herein are devices configured for tissue ablation having hollow inner conductors for distal tip sensing access. In particular, energy delivery devices are provided having one or more sensors (e.g., positioning sensors, temperature sensors) positioned outside the distal end of a hollow inner conductor (e.g., within a region configured for ablation energy emission). In certain embodiments, such devices are utilized in systems and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.).

The present invention provides nanodroplets labeled with targeting ligands that can be used to detect and treat vascular thrombosis (e.g., fibrin clots) and vascular plaques, or related diseases and disorders, as well as methods of making and using the same.

Provided herein are devices, systems, and methods for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In certain embodiments, devices, systems, and methods are provided for delivering energy to difficult to access tissue regions (e.g. central or peripheral lung tissues), and / or reducing the amount of undesired heat given off during energy delivery.

A system for predicting at least partial rupture or detachment of a vascular plaque that may lead to a stroke or for analyzing the biomechanical properties of the wall of an internal jugular vein in order to predict a risk of thrombosis, comprising: a monitoring device (2) including a temperature sensor (5) configured to measure the temperature of the vascular plaque or the wall of the jugular vein, a vibration sensor (4) configured to measure mechanical waves passing through the vascular plaque and the underlying walls, a motion sensor (6) configured to measure the movements of the plaque or the wall of the jugular vein (6), an electrical sensor configured to measure a parameter related to the electrical impedance of the plaque, an acoustic wave sensor, and a computing unit (10) configured to analyze the data from the monitoring device (2) by artificial intelligence.Figure from the summary: Figure 1.

Disclosed herein, are peptides that bind coagulation factor XII (FXII). Also described herein, are methods of administering compounds comprising peptides that bind coagulation FXII to subjects for the treatment of cancer-associated thrombosis, sickle cell disease associated with vaso-occlusive crisis or vascular thrombosis, colon cancer, glioblastoma multiforme, organ fibrosis, Alzheimer's disease, and autoimmune encephalitis.

The present invention relates to systems and devices for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In particular, the present invention relates to systems and devices for the delivery of energy with a linear array of antenna components having optimized energy delivery characteristics. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of energy with the systems and devices of the present invention.